Ligand Pharmaceuticals
LGND
#2772
Rank
ยฃ4.56 B
Marketcap
ยฃ228.15
Share price
2.41%
Change (1 day)
43.39%
Change (1 year)

Operating Margin for Ligand Pharmaceuticals (LGND)

Operating Margin as of November 2026 (TTM): 59.29%

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 59.29%. At the end of 2021 the company had an Operating Margin of 17.07%.

Operating Margin history for Ligand Pharmaceuticals from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202117.07%-401.92%
2020-5.65%-100.85%
2019662.31%860.82%
201868.93%69.95%
201740.56%455.27%
20167.30%-85.13%
201549.13%180.53%
201417.51%-6.84%
201318.80%-252.66%
2012-12.31%25.29%
2011-9.83%-84.98%
2010-65.44%158.12%
2009-25.35%-92.9%
2008-357.00%-13.89%
2007-414.58%235.33%
2006-123.63%-700.84%
200520.58%-174.92%
2004-27.46%102.13%
2003-13.59%-45.63%
2002-24.99%-17.54%
2001-30.31%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-41.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.01%-79.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
40.21%-32.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
27.00%-54.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-4.21%-107.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-45.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
22.64%-61.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
16.02%-72.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-109.76%-285.12%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.